{"id":"W3157675313","doi":"10.1136/jitc-2021-002535","title":"Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Canadian Cancer Society; ECOG-ACRIN Cancer Research Group; National Cancer Institute; National Institutes of Health; American College of Radiology Imaging Network; Bristol-Myers Squibb","keywords":"Ipilimumab; Medicine; Rash; Internal medicine; Adverse effect; Adjuvant; Melanoma; Oncology; Multivariate analysis; Proportional hazards model; Immunotherapy; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001734582,0.0004535606,0.0005957834,0.0004873624,0.000146687,0.0005447369,0.0003967227,0.0003443261,0.0009935957],"category_scores_gemma":[0.001180045,0.0001815042,0.001440111,0.0006952825,0.0001877974,0.0003942027,0.0004504972,0.0005693644,0.0001652762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002342517,"about_ca_system_score_gemma":0.0001908405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005385328,"about_ca_topic_score_gemma":0.00083507,"domain_scores_codex":[0.9995056,0.0001887201,0.00006684073,0.0001079341,0.00007857817,0.00005232997],"domain_scores_gemma":[0.997964,0.000370788,0.001185026,0.000145546,0.00008841588,0.0002461864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006700414,0.00008361088,0.9880016,0.00009937848,0.001525593,0.00007842075,0.00001487449,0.0003940069,0.000341085,0.00001948723,0.0001558857,0.002585539],"study_design_scores_gemma":[0.000462932,0.001613855,0.9949409,0.00002758362,0.001072782,0.0003207588,0.00003850998,0.0007864195,0.0001790999,0.00005226435,0.000496621,0.000008251852],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973464,0.001493557,0.000131785,0.00002004152,0.00000657268,0.00002574037,0.0006440582,0.000003754438,0.0003280183],"genre_scores_gemma":[0.9988776,0.000225091,0.00005054982,0.0000217197,0.0000162602,0.00001999535,0.0006487864,0.000001961185,0.0001379492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001734582,"threshold_uncertainty_score":0.009173453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02425938821284489,"score_gpt":0.3273518728818649,"score_spread":0.30309248466902,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}